PharmaEngine, Inc. (TPEX:4162)

PharmaEngine Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,011	993.7	875.62	1,769	2,151	1,836
Short-Term Investments	2,657	2,867	2,752	1,837	1,663	1,558
Trading Asset Securities	-	-	-	55.59	-	-
Cash & Short-Term Investments	5,668	3,861	3,628	3,661	3,814	3,394
Cash Growth	52.76%	6.42%	-0.91%	-4.00%	12.37%	-0.64%
Accounts Receivable	178.8	1,844	174.17	160.34	160.48	644.52
Other Receivables	64.85	87.59	97.41	63.51	22.83	95.81
Receivables	243.65	1,932	271.58	223.85	183.31	740.33
Inventory	15.3	28.38	15.9	34.38	5.43	24.74
Prepaid Expenses	6.9	6.4	7.48	6.57	6.48	10.56
Other Current Assets	-	-	-	-	0.08	0.48
Total Current Assets	5,934	5,827	3,923	3,926	4,009	4,170
Property, Plant & Equipment	9.94	10.24	18.03	25.92	7.89	22.95
Other Intangible Assets	1.61	1.78	1.88	2.51	0.6	0.83
Long-Term Deferred Tax Assets	5.59	5.91	8	9.54	4.98	6.84
Other Long-Term Assets	2.48	2.44	2.98	2.5	3.9	6.44
Total Assets	5,953	5,848	3,954	3,967	4,026	4,207
Accrued Expenses	91.54	99.31	67.22	61.31	64.14	48.22
Current Portion of Leases	6.08	7.14	7.67	7.54	7.59	10.77
Current Income Taxes Payable	338.73	327.9	-	-	6.92	34.69
Other Current Liabilities	8.38	8.7	8.98	9.9	9.06	90.78
Total Current Liabilities	444.73	443.05	83.86	78.74	87.71	184.46
Long-Term Leases	0.89	-	7.14	14.81	-	11.31
Long-Term Deferred Tax Liabilities	5.26	4.96	-	0.92	-	0
Total Liabilities	450.88	448.01	91.01	94.47	87.71	195.78
Common Stock	1,457	1,457	1,457	1,457	1,466	1,466
Additional Paid-In Capital	1,616	1,616	1,616	1,617	1,620	1,620
Retained Earnings	2,563	2,461	925.31	937.85	1,101	1,039
Treasury Stock	-133.41	-133.41	-133.41	-133.41	-248.24	-114.83
Comprehensive Income & Other	-0.23	-0.41	-1.79	-5.97	-	1.21
Shareholders' Equity	5,502	5,400	3,863	3,872	3,939	4,011
Total Liabilities & Equity	5,953	5,848	3,954	3,967	4,026	4,207
Total Debt	6.97	7.14	14.81	22.35	7.59	22.08
Net Cash (Debt)	5,661	3,854	3,613	3,639	3,806	3,372
Net Cash Growth	53.10%	6.65%	-0.71%	-4.39%	12.88%	-0.33%
Net Cash Per Share	39.32	26.78	25.14	25.32	26.30	23.11
Filing Date Shares Outstanding	143.68	143.68	143.68	143.69	143.6	145.6
Total Common Shares Outstanding	143.68	143.68	143.68	143.69	143.6	145.6
Working Capital	5,489	5,384	3,839	3,847	3,921	3,985
Book Value Per Share	38.30	37.58	26.89	26.95	27.43	27.55
Tangible Book Value	5,501	5,398	3,861	3,870	3,938	4,010
Tangible Book Value Per Share	38.28	37.57	26.87	26.93	27.42	27.54
Machinery	5.28	5.18	4.44	4.03	0.8	4.97
Leasehold Improvements	-	-	7.69	7.69	7.69	9.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.